Argatroban (Sandoz Inc)


Welcome to the PulseAid listing for the Argatroban drug offered from Sandoz Inc. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: Argatroban
SUBSTANCE NAME: ARGATROBAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-05-09
END MARKETING DATE: 0000-00-00


Argatroban HUMAN PRESCRIPTION DRUG Details:

Item DescriptionArgatroban from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 125(mg/125mL)
START MARKETING DATE: 2011-05-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-3285_1ae496ee-dc66-4bc0-9676-f8c47f7044e6
PRODUCT NDC: 0781-3285
APPLICATION NUMBER: NDA022485

Other ARGATROBAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Eagle Pharmaceuticals, Inc.Argatroban
Fresenius Kabi USA, LLCArgatroban
Gland Pharma LimitedArgatroban
GlaxoSmithKline LLCARGATROBAN
Hospira, Inc.Argatroban
Par Pharmaceutical, Inc.Argatroban
Sandoz IncArgatroban
Teva Parenteral Medicines, Inc.Argatroban
West-Ward Pharmaceuticals CorpArgatroban